![Roberto Bellini](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roberto Bellini
Direktör/Styrelseledamot på
INHIBIKASE THERAPEUTICS, INC.
Förmögenhet: - $ per 2026-06-30
Profil
Roberto Bellini currently works at BIOTECanada, as Vice Chairman from 2016, Klox Technologies Europe Ltd., as Director, Inhibikase Therapeutics, Inc., as Independent Director from 2025, and Bsquared Capital, Inc., as Managing Partner from 2023.
Mr. Bellini also formerly worked at BELLUS Health, Inc., as President, CEO & Head-Investor Relations from 2010 to 2012, Thallion Pharmaceuticals, Inc., as Independent Director from 2010 to 2013, CellCarta Biosciences, Inc., as Director, Picchio Pharma, Inc., as Executive Vice President, and Prognomix, Inc., as Vice President-Corporate Development.
Mr. Bellini received his undergraduate degree in 2002 from McGill University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-26 | 0 ( -.--% ) | - $ | 2026-06-30 |
Aktiva positioner av Roberto Bellini
| Företag | Position | Start |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2025-02-14 |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Direktör/Styrelseledamot | 2016-05-04 |
FB Dermatology Ltd.
 FB Dermatology Ltd. Pharmaceuticals: OtherHealth Technology Provides skin treatment services | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Roberto Bellini
| Företag | Position | Slut |
|---|---|---|
| BELLUS HEALTH | Verkställande Direktör | 2023-06-30 |
| THALLION PHARMACEUTICALS INC. | Direktör/Styrelseledamot | 2013-04-24 |
Picchio Pharma, Inc.
 Picchio Pharma, Inc. Pharmaceuticals: GenericHealth Technology Engages in acquiring, developing, and commercializing new therapeutic products | Företagsledare/Principal | 2009-12-01 |
Prognomix, Inc.
 Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Develops market molecular diagnostic kits for testing of diabetes complications | Företagsledare/Principal | - |
CellCarta Biosciences, Inc.
 CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as specialty contract research laboratory | Direktör/Styrelseledamot | - |
Roberto Bellinis utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
87
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
BELLUS Health, Inc.
 BELLUS Health, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for the treatment of refractory chronic disease | Health Technology |
Picchio Pharma, Inc.
Picchio Pharma, Inc. Pharmaceuticals: GenericHealth Technology Engages in acquiring, developing, and commercializing new therapeutic products | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thallion Pharmaceuticals, Inc.
 Thallion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops new pharmaceutical products | Health Technology |
CellCarta Biosciences, Inc.
CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as specialty contract research laboratory | Commercial Services |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Prognomix, Inc.
Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Develops market molecular diagnostic kits for testing of diabetes complications | Health Technology |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
FB Dermatology Ltd.
FB Dermatology Ltd. Pharmaceuticals: OtherHealth Technology Provides skin treatment services | Health Technology |
